Contraception
Conditions
Keywords
Contraception, Compliance
Brief summary
Adherence to the dosing scheme is the principal element of COC efficiency. On the other hand noncompliance seemed to be an inseparable element of any oral treatment. The aim of the study is to evaluate in everyday practice the relation between dosage errors and indicated factors, potentially influencing the compliance with the dosing scheme.
Interventions
DRUGQlaira or Yaz (BSP products defined as Combined Oral Contraceptive) and Cerazette or Azalia (competitor's products defined as Progestogen Only Pill)
One tablet per day, orally, 28 tablets per cycle, during three consecutive cycles.
Sponsors
Bayer
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Patients at the age of 18-50 requiring contraception, treated with oral contraceptives designed for the scheme 28 pills for 28 days. The decisions would be made at the discretion of the attending physician.
Exclusion criteria
* Patients were not valid for analysis if the initial visit was before start of study in the country (retrospective documentation), or if they did not take oral contraceptives designed for the scheme 28 pills for 28 days.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of users showing noncompliant behaviors | 3 consecutive cycles (28-days per cycle) |
Secondary
| Measure | Time frame |
|---|---|
| The characteristics of noncompliant behavior. | 3 consecutive cycles (28-days per cycle) |
| The relation between noncompliant behavior and selected factors. | 3 consecutive cycles (28-days per cycle) |
Countries
Poland
Outcome results
None listed